Director, HEOR

About the role

At Neurocrine Biosciences, we pride ourselves on having a strong, inclusive, and positive culture based on our shared purpose and values. We know what it takes to be great, and we are as passionate about our people as we are about our purpose - to relieve suffering for people with great needs. What We Do: Neurocrine Biosciences is a leading neuroscience-focused, biopharmaceutical company with a simple purpose: to relieve suffering for people with great needs. We are dedicated to discovering and developing life-changing treatments for patients with under-addressed neurological, neuroendocrine and neuropsychiatric disorders. The company's diverse portfolio includes FDA-approved treatments for tardive dyskinesia, chorea associated with Huntington's disease, classic congenital adrenal hyperplasia, endometriosis* and uterine fibroids,* as well as a robust pipeline including multiple compounds in mid- to late-phase clinical development across our core therapeutic areas. For three decades, we have applied our unique insight into neuroscience and the interconnections between brain and body systems to treat complex conditions. We relentlessly pursue medicines to ease the burden of debilitating diseases and disorders because you deserve brave science. For more information, visit neurocrine.com , and follow the company on LinkedIn , X and Facebook . ( *in collaboration with AbbVie ) Develops strategies for and successfully executes completion of product/disease specific projects to determine and express the health care value of Neurocrine marketed products or developmental compounds. Works closely with the U.S. Product Developmental Team, Key Stakeholders within the Medical Affairs team, Brand Team, Clinical Team and Departments dedicated to Managed Care or Health Care Advocacy to develop information that allows, patient, clinicians and payers to make informed health care decisions regarding Neurocrine products. This role will also contribute to the development of evidence strategies supporting federal value assessment processes, including activities related to the Inflation Reduction Act (IRA). The Director will partner cross-functionally to ensure that clinical, economic, and real-world evidence are synthesized into clear, compelling value narratives appropriate for senior internal stakeholders and external policy audiences. _ Your Contributions (include, but are not limited to): Develops strategy for work area and translates into operational and tactical plans Sets strategy, designs, develops and implements projects to assist in the creation of product specific evidence to inform value assessment and market access Acts as the U.S. brand lead for HEOR content and support Collaborates with internal business partners to meet the evidence needs of external consumers Manages vendors and relationships from selection to potential ending relationship Assists in meeting the corporate and departmental goals. Selects, develops and evaluates personnel to ensure the efficient operation of the function Provide direction to subordinate managers in various areas, groups, and/or operations Directs the resolution of highly complex or unusual business / scientific problems that impact success or address future processes / outcomes Applies advanced analytical thought and judgment Develops new or innovative solutions to existing and/or novel problems Regularly interacts with senior leadership to influence policy and negotiate decisions within area of responsibility Represents Neurocrine at professional events and may present data and findings Contributes to evidence strategy and content development supporting federal pricing and value assessment frameworks, including Medicare Drug Price Negotiation (IRA) Synthesizes complex clinical, economic, and real-world data into concise, defensible value narratives tailored for senior leadership and external stakeholders Provides strategic counsel to cross-functional leadership on value positioning in high-visibility, high-impact business contexts Other duties as assigned